In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

This content is currently on FREE ACCESS

The link between myocardial perfusion and integrated CT indices of atherosclerotic burden in patients with coronary artery disease

Session Moderated Posters 5

Speaker Konstantin Zavadovskiy

Event : ICNC, Nuclear Cardiology & Cardiac CT 2019

  • Topic : imaging
  • Sub-topic : Hybrid and Fusion Imaging
  • Session type : Moderated Posters

Authors : K Zavadovskiy (Tomsk,RU), EV Grakova (Tomsk,RU), VV Saushkin (Tomsk,RU), MO Gulya (Tomsk,RU), R Liga (Pisa,IT), A Gimelli (Pisa,IT)

K Zavadovskiy1 , EV Grakova2 , VV Saushkin3 , MO Gulya3 , R Liga4 , A Gimelli5 , 1State Research Institute of Cardiology of Tomsk, Nuclear Medicine - Tomsk - Russian Federation , 2Cardiology Research Institute, Tomsk National Research Medical Centre, Russian Academy of Sciences, Myocardial Pathology - Tomsk - Russian Federation , 3Cardiology Research Institute, Tomsk National Research Medical Centre, Russian Academy of Sciences, Nuclear Medicine - Tomsk - Russian Federation , 4University of Pisa - Pisa - Italy , 5Fondazione Toscana/CNR Gabriele Monasterio, Nuclear Cardiology - Pisa - Italy ,


Purpose. To assess myocardial perfusion in stable CAD patients with different degrees of coronary artery stenosis.

Methods. We selected 94 patients with intermediate pre-test probability of CAD. All patients underwent coronary CT angiography (CCTA) and stress-rest MPI using GE Discovery NM/CT 570?. Coronary plaques were considered significant (=70%), intermediate (40% to 69%) and non-significant (<40%). The Segment Involvement Score (SIS) was calculated as the total number of coronary artery segments with atherosclerotic plaques. The Segment Stenosis Score (SStS) was computed by grading each coronary segment with a 5-point scoring system (0 = no plaque; 1 = 1-24% stenosis; 2 = 25-49% stenosis; 3 = 50-69% stenosis; and 4 = =70% stenosis). The summed rest score (SRS), stress score (SSS), and difference score (SDS) were derived from MPI images.

 Results. The median SIS and SStS were 4.0 (IQR 2.0- 5.0) and 7.5 (IQR 3.0; 13.0), respectively. Normal MPI images were observed in 40(43%) patients, abnormal in 56(54%). There were 378 segments with atherosclerotic plaques: 24(6%) in the LM, 178(47%) in the LAD, 78(21%) in the LCx, and 98(26%) in the RCA. The frequencies of normal and abnormal MPI in patients with <40% (normal MPI 53%; abnormal MPI 47%) and 40% to 69% (normal MPI 44%; abnormal MPI 56%) coronary artery stenosis did not significantly differ (p=0.40 and p=0.22, respectively). In patients with =70% coronary artery stenosis, abnormal MPI was observed significantly more often (normal MPI 29%; abnormal MPI 71%) than normal MPI (p=0.001). In the overall population, both Segment Involvement Score and Segment Stenosis Score had weak correlations with SSS (r=0.3 and r=0.34, respectively; P<0.01 for both), SRS (r=0.27 and r=0.35, respectively; P<0.01 for both), and SDS (r=0.3 and r=0.36, respectively; P<0.01 for both). In patients with <40% stenosis neither CT scores correlated with MPI parameters, while SDS correlated moderately with Segment Involvement Score (r=0.45; p=0.03) and Segment Stenosis Score (r=0.53; p=0.01) in those with 40% to 69% stenosis. In patients with =70% stenosis, the Segment Stenosis Score had moderate correlations with SSS (r=0.50; p=0.005) and SDS (r=0.43; p=0.02).

Conclusion. Myocardial ischemia may frequently develop even in the absence of critical coronary artery lesions, presenting in a consistent proportion of patients with either intermediate or even non-significant coronary stenosis. In those patients, the extent of regional myocardial perfusion defects correlates more with measures of global CAD burden than with focal stenosis severity, as a sign of the significant inter-relation between diffuse coronary atherosclerosis and myocardial ischemia.

Based on your interests

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are